NCT02004704: A reported trial by Genzyme, a Sanofi Company
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT02004704 |
|---|---|
| Title | A Long-Term Study to Assess the Ongoing Safety and Efficacy of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Dec. 4, 2013 |
| Completion date | Sept. 6, 2023 |
| Required reporting date | Sept. 5, 2024, midnight |
| Actual reporting date | April 23, 2024 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |